Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study

NCT02449330 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

936

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Teneligliptin

Sponsor

National Cerebral and Cardiovascular Center, Japan